161 related articles for article (PubMed ID: 10577925)
1. Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.
Toren A; Amariglio N; Rozenfeld-Granot G; Simon AJ; Brok-Simoni F; Pras E; Rechavi G
Am J Hum Genet; 1999 Dec; 65(6):1711-7. PubMed ID: 10577925
[TBL] [Abstract][Full Text] [Related]
2. Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13.
Toren A; Rozenfeld-Granot G; Rocca B; Epstein CJ; Amariglio N; Laghi F; Landolfi R; Brok-Simoni F; Carlsson LE; Rechavi G; Greinacher A
Blood; 2000 Nov; 96(10):3447-51. PubMed ID: 11071640
[TBL] [Abstract][Full Text] [Related]
3. Localisation of the gene responsible for fechtner syndrome in a region <600 Kb on 22q11-q13.
Cusano R; Gangarossa S; Forabosco P; Caridi G; Ghiggeri GM; Russo G; Iolascon A; Ravazzolo R; Seri M
Eur J Hum Genet; 2000 Nov; 8(11):895-9. PubMed ID: 11093280
[TBL] [Abstract][Full Text] [Related]
4. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
[TBL] [Abstract][Full Text] [Related]
5. Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12-13.
Kelley MJ; Jawien W; Lin A; Hoffmeister K; Pugh EW; Doheny KF; Korczak JF
Hum Genet; 2000 May; 106(5):557-64. PubMed ID: 10914687
[TBL] [Abstract][Full Text] [Related]
6. [Fechtner syndrome. A rare differential Alport syndrome diagnosis].
Delb W; Schenk J; Iro H
HNO; 2000 Aug; 48(8):616-20. PubMed ID: 10994174
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).
Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP
Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635
[TBL] [Abstract][Full Text] [Related]
8. Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia.
Peterson LC; Rao KV; Crosson JT; White JG
Blood; 1985 Feb; 65(2):397-406. PubMed ID: 2981587
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia.
Ciccarese M; Casu D; Ki Wong F; Faedda R; Arvidsson S; Tonolo G; Luthman H; Satta A
Nephrol Dial Transplant; 2001 Oct; 16(10):2008-12. PubMed ID: 11572889
[TBL] [Abstract][Full Text] [Related]
10. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
[TBL] [Abstract][Full Text] [Related]
11. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
12. The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.
Martignetti JA; Heath KE; Harris J; Bizzaro N; Savoia A; Balduini CL; Desnick RJ
Am J Hum Genet; 2000 Apr; 66(4):1449-54. PubMed ID: 10739770
[TBL] [Abstract][Full Text] [Related]
13. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
[TBL] [Abstract][Full Text] [Related]
14. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
15. Mapping of a gene for May-Hegglin anomaly to chromosome 22q.
Kunishima S; Kojima T; Tanaka T; Kamiya T; Ozawa K; Nakamura Y; Saito H
Hum Genet; 1999 Nov; 105(5):379-83. PubMed ID: 10598801
[TBL] [Abstract][Full Text] [Related]
16. Fechtner syndrome: clinical and genetic aspects.
Gershoni-Baruch R; Baruch Y; Viener A; Lichtig C
Am J Med Genet; 1988 Oct; 31(2):357-67. PubMed ID: 3232700
[TBL] [Abstract][Full Text] [Related]
17. Fechtner syndrome: report of a third family and literature review.
Rocca B; Laghi F; Zini G; Maggiano N; Landolfi R
Br J Haematol; 1993 Oct; 85(2):423-6. PubMed ID: 8280620
[TBL] [Abstract][Full Text] [Related]
18. Familial hematuric syndromes--Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes.
Kashtan CE
Contrib Nephrol; 2001; (136):79-99. PubMed ID: 11688406
[No Abstract] [Full Text] [Related]
19. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
[TBL] [Abstract][Full Text] [Related]
20. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12.
Xiong L; Labuda M; Li DS; Hudson TJ; Desbiens R; Patry G; Verret S; Langevin P; Mercho S; Seni MH; Scheffer I; Dubeau F; Berkovic SF; Andermann F; Andermann E; Pandolfo M
Am J Hum Genet; 1999 Dec; 65(6):1698-710. PubMed ID: 10577924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
